Cointime

Download App
iOS & Android

The Use of Blockchain to Fight Drug Counterfeiting in the Pharmaceutical Industry

Drug counterfeiting is a huge problem worldwide. The prevalence of counterfeit drugs is especially problematic in emerging markets, where regulatory controls are often lax, and the demand for cheap medicines is high.

In fact, it is estimated that counterfeit drugs make up 10% of the global market, costing the industry billions of dollars each year. Despite pharmaceutical companies’ best efforts, the booming counterfeiting market is always prepared to outsmart them in a game of cat and mouse. Keeping tabs on suppliers and verifying authentic supply chains has become quite challenging.

From lax regulation to global trends, the challenges of counterfeit drugs are ever evolving. The pharmaceutical industry feels this impact as healthcare costs rise worldwide; drug counterfeiting could soon become an epidemic if anti-counterfeit strategies aren’t implemented quickly and effectively. As globalization continues to open new markets with increased demand for pharmaceuticals, we must intervene before these nefarious practices spiral out of control.

But what if there were a way to fight back against these counterfeiters? That’s where blockchain comes in.

Infusing Blockchain in the Pharmaceutical Industry

The health sector has been abuzz with the news of blockchain technology coming to revolutionize pharmaceuticals — and its potential continues to drive widespread excitement as trials continue.

Blockchain technology is the ultimate data protector, offering a foolproof system against malicious hacking and corruption. Its decentralized network uses a secure sharing protocol so only authorized parties can access valuable information about products throughout their entire supply chain journey — from origin to consumer — ensuring that drugs stay safe in transit.

Blockchain is an Ideal Technology for Pharmaceutical Track and Trace

Blockchain is shaking up healthcare, allowing drug manufacturers to create a secure ecosystem where data security and quality are top-notch. Everyone involved can easily access the necessary information — never before has it been so easy or promising for healthcare professionals to benefit from such a revolutionary technology.

With the addition of serial numbers to a blockchain, products get an unchanging identity. This is then kept safe through two hallmarks of blocks — decentralization and checksums. Firstly, all involved parties must sign off on any changes made while heightened levels of accuracy are enabled by cryptographic hash functions that mean alterations can never be reversed.

This platform provides a safe and secure way to get pharmaceuticals and carry out transactions. Buyers, sellers, manufacturers — everyone can experience an expedited process free from unnecessary intermediaries. Traceability is guaranteed, so you won’t have to worry about unexpected changes.

Data Security

Blockchain technology provides a safe haven for safeguarding patients’ medical records. It keeps the data secure and grants only those with permission access to confidential information, ensuring people’s rights aren’t compromised. In addition, it helps combat counterfeit drugs by offering fair pricing that leaves no room for deception! The smart contracts on its permissioned blockchain are explicitly designed to prevent shady actors from accessing sensitive patient details.

Vendor credentialing

Blockchain technology provides rigorous vendor credentialing of drug suppliers to ensure patients receive the best medication quality and safety. This vital step verifies their trustworthiness before any purchases are made — ensuring the drugs they provide meet even health ministry standards.

Buyer assurance

Blockchain technology has given consumers the power to verify a drug’s authenticity with just one scan. Combining QR codes, RFID, and GPS tech makes it easier than ever for companies to identify counterfeit products. As a bonus, buyers can now check product history before purchasing — giving them peace of mind that what they’re getting is genuine merchandise.

Tracing and tracking

Thanks to blockchain technology, supply chain tracing and tracking have reached the next level. The origin of drugs can easily be identified along with a complete list of designated destinations each item is likely to pass through. Software-facilitated decentralization ensures smooth sailing while maintaining high product quality throughout the entire process — now that’s something worth celebrating.

Transparency

By leveraging the public ledger of blockchain tech, all parties have crystal-clear visibility throughout the drug supply chain. So no one needs to worry about a sudden change during transit as everyone involved in the supply process is ‘in the know.’ Everyone has access to essential product information, and any changes during shipping or receiving can be made with a few clicks. With this system in place, counterfeit drugs don’t stand a chance.

Closing Thoughts

The pharmaceutical industry is jumping on the blockchain bandwagon and ushering in a new era of drug serialization that is much more effective than its predecessors. From El Salvador legalizing Bitcoin as a legal tender to World Health Organization giving their support, it’s clear that this groundbreaking technology isn’t going anywhere anytime soon! With features like anonymity, decentralization, tamper-proofing, and transparency, efficient tracking of drugs will help end patient health risks for good.

Comments

All Comments

Recommended for you

  • U.S. July Nonfarm Payrolls Fall by 23,000, Missing Market Expectations

    On August 7, U.S. nonfarm payrolls decreased by 23,000 in July, compared with market expectations of an increase of 80,000, and the previous value was an increase of 57,000.

  • US May and June Nonfarm Payroll Additions Revised Down by 103,000 Combined

    On August 7, the US Bureau of Labor Statistics: May nonfarm payroll additions were revised down from 129,000 to 63,000; June nonfarm payroll additions were revised down from 57,000 to 20,000. After the revisions, the combined additions for May and June were 103,000 lower than previously reported.

  • U.S. Rate Futures Market Sees Lower Odds of Fed September Hike

    On August 7, the probability of a Fed rate hike in September as priced by U.S. interest rate futures declined.

  • New York Gold Futures Top $4,400 per Ounce

    New York gold futures topped $4,400 per ounce, up 2.36% on the day.

  • Japan Finance Minister: FX Market Affected by Moves Not Driven by Actual Demand

    Japanese Finance Minister Satsuki Katayama said she and U.S. Treasury Secretary Bessent agreed that the foreign exchange market has been affected by moves not driven by actual demand.

  • BTC Breaks Through $65,000

    Market data shows BTC has broken through $65,000, currently reported at $65,007.44, with a 24-hour increase of 0.6%. The market is highly volatile, please exercise risk control.

  • Brent Crude Drops 2.00% Intraday to $81.07/Barrel

    Brent crude oil fell 2.00% during the day, now at $81.07 per barrel. (Jin Shi)

  • Trump: Data Centers May Be More Important Than Oil

    August 7 news, U.S. President Trump said in an interview with Punchbowl News, "I saw the other day that Texas seems to be opposed to building data centers. I think that's a mistake. I'm not taking a position—I just think it's a mistake, because there are other communities that want to build data centers. When a community is willing to accept data centers, it means a lot of money will flow into that community. I don't think they're ugly. Some of the data centers I've seen are the most incredible buildings I've ever seen. They are very important to the economy. If Texas says no to data centers, that's a mistake, because data centers may be more important than oil."

  • Trump to Meet with Mining Executives

    On August 7, according to CCTV International News, US President Trump will convene executives from some of the world's largest mining companies at the US State Department on August 7 local time, in an effort to take action to 'secure critical mineral supplies for the US and its allies.' Reuters reported that the US urgently needs critical minerals to replenish weapons inventories depleted during the war against Iran. During the more than five-month war with Iran, the US military expended large quantities of precision-guided missiles and air defense interceptors. US defense officials and lawmakers have warned that given existing production capacity constraints, replenishing some stockpiles could take years—although the Trump administration has denied reports of a so-called 'severe shortage of ammunition stockpiles.' According to Pentagon officials and defense companies, supplies of minerals such as rare earths, tungsten, germanium, and scandium are essential for manufacturing precision-guided missiles, fighter jets, armored vehicles, infrared sensors, and other advanced weapons systems. Expected attendees include industry giants such as global mining giant Rio Tinto Group, Australia's BHP, US Freeport-McMoRan, US Mountain Pass Materials, US Rare Earths, US Energy Fuels, and Canada's Metals Company. According to sources, the Trump administration plans to announce multiple deals and memorandums of understanding.

  • US Regulators Systematically Review Chinese AI Firms' Third-Country Computing Power Leasing

    August 7 news, according to Bloomberg, people familiar with the matter revealed that the U.S. government department responsible for investigating chip export control violations is reviewing Chinese AI companies' leasing of computing power in third countries to obtain Nvidia advanced chips.